Compare BOOT & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BOOT | ITGR |
|---|---|---|
| Founded | 1978 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 2.6B |
| IPO Year | 2014 | 2000 |
| Metric | BOOT | ITGR |
|---|---|---|
| Price | $190.23 | $79.54 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 8 |
| Target Price | ★ $203.67 | $95.00 |
| AVG Volume (30 Days) | 522.5K | ★ 650.3K |
| Earning Date | 01-29-2026 | 10-23-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.30 | N/A |
| EPS | ★ 6.78 | 2.42 |
| Revenue | ★ $2,071,382,000.00 | $1,831,074,000.00 |
| Revenue This Year | $18.94 | $9.58 |
| Revenue Next Year | $13.11 | N/A |
| P/E Ratio | ★ $27.93 | $32.67 |
| Revenue Growth | ★ 17.82 | 9.54 |
| 52 Week Low | $86.17 | $62.00 |
| 52 Week High | $210.25 | $146.36 |
| Indicator | BOOT | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 45.88 | 67.62 |
| Support Level | $184.88 | $75.64 |
| Resistance Level | $209.84 | $80.95 |
| Average True Range (ATR) | 7.59 | 2.10 |
| MACD | -1.73 | 1.39 |
| Stochastic Oscillator | 17.93 | 84.53 |
Boot Barn Holdings Inc operates specialty retail stores. The company sells western and work-related footwear, apparel, and accessories in the United States. It is a single operating segment, which includes net sales generated from its retail stores and e-commerce websites.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.